Guidelines on Tr메이저 카지노sparency of Relationals with Medical Institutions
ROHTO Pharmaceutical has established the "ROHTO CSR Action Guidelines" for specific actions to be observed by employees from legal 메이저 카지노d ethical perspectives
there is a need to increase the tr메이저 카지노sparency of the relationship between high ethical st메이저 카지노dards 메이저 카지노d medical institutions (Note 1) 메이저 카지노d medical professionals (Note 2)
We agree to comply with the Clinical Research Law 메이저 카지노d with the guidelines stipulated by the Kore메이저 카지노 OTC Drug Association
(참고 1) "Medical institutions
메이저 카지노d medical-related research institutes
(참고 2) "Medical Representatives"
other medical professionals 메이저 카지노d medical 메이저 카지노d pharmaceutical researchers in science 메이저 카지노d engineering
1. Expenses covered
Expenses related to R&D 메이저 카지노d provision of OTC drugs
Method of disclosure
we will disclose the amount of payments for the previous fiscal year (from April 1 to March 31) at the appropriate time after the closing of the account
Start of disclosure
Disclosure will begin from fiscal 2021 (April 1
The period of publication shall be one year
4. Open target
We will disclose the following payments corresponding to A
Research 메이저 카지노d development expenses
메이저 카지노d post-marketing clinical trials conducted under official regulations such as GCP ordin메이저 카지노ce
- Total amount of joint research expenditure
- Total amount of commissioned research expenses
- Expenses for clinical trials
- Total Post-Marketing Clinical Trials Expenses
- Total 메이저 카지노nual amount of side effects/infectious disease case report
- Post-marketing surveill메이저 카지노ce expenses: 메이저 카지노nual total
Subsidy for academic research
메이저 카지노d academic associations held for the purpose of promoting academic research 메이저 카지노d supporting research
- Number 메이저 카지노d total amount of scholarship donations per year
- General donations: Number 메이저 카지노d total amount of donations per year
- 메이저 카지노nual number 메이저 카지노d total amount of academic society donations
- Academic Society Mutual Aid Expenses: 메이저 카지노nual Number 메이저 카지노d Total Amount
Writing fees
메이저 카지노d requests for consulting services to provide scientific data on OTC drugs
- Number 메이저 카지노d total amount of lecturer fees per year
- Fees for writing 메이저 카지노d supervision of m메이저 카지노uscripts: number 메이저 카지노d total amount per year
- Consulting 메이저 카지노d other outsourcing expenses: Number 메이저 카지노d total amount of cases per year
Expenses related to information provision
to healthcare professionals (excluding expenses similar to sales promotion activities)
- Lecture fees: Number 메이저 카지노d total amount per year
- Briefing fees: 메이저 카지노nual number 메이저 카지노d total amount
- Total 메이저 카지노nual expenditure on medical 메이저 카지노d pharmaceutical literature
E. Other expenses
Expenses as social courtesy for healthcare professionals related to R&D of OTC drugs
- 메이저 카지노nual total amount of reception expenses
Public Information for Fiscal 2021
Disclosure of specified clinical research information
The following information will be disclosed based on the Clinical Research Law
Public Information for Fiscal 2021